GlassScriptPhysician profile
Catherine Diane Amble
NPI 1841674785
$994.02
in general payments reported to CMS, 2019-2025
11 companies · $23.09 in 2025
The $23.09 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $346 · 2020: $282 · 2021: $18.13 · 2022: $141 · 2023: $37.26 · 2024: $146 · 2025: $23.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $205.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $268.75 | 2020 | |
| Abbvie INC. | $161.01 | 2019-2022 | |
| Axonics, INC. | $145.60 | 2024 | Bulkamid |
| Tesaro, INC. | $108.16 | 2019 | |
| Exeltis, USA INC. | $104.56 | 2022-2023 | Slynd |
| Genentech USA, INC. | $84.01 | 2019 | |
| Baxter Healthcare | $56.10 | 2019 | |
| Biogen, INC. | $23.09 | 2025 | Zurzuvae |
| Organon LLC | $17.39 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.67 | 2020 | |
| Merck Sharp & Dohme LLC | $11.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Amble listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.